Takefumi Suzuki, MD, PhD
- 17Articles
- 71.5KReads
- 2009–2021Active
- 56Collaborators
- 157Citations
About
Takefumi Suzuki, MD, PhD, is affiliated with the Department of Neuropsychiatry at Keio University School of Medicine and the Department of Neuropsychiatry and Clinical Ethics at the University of Yamanashi in Japan. Suzuki has published extensively on psychiatric and neurological disorders, including schizophrenia, bipolar disorder, depression, Alzheimer's disease, dementia, and movement disorders. The research focuses on psychotropic drug dosing regimens, dopamine receptor occupancy, placebo effects, and comorbid psychiatric conditions in medical illnesses. Suzuki's work also addresses clinical pharmacology and treatment strategies in neuropsychiatric conditions.
Publications
Central and Peripheral Pharmacokinetics of Antipsychotics
July 28, 2020
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
October 26, 2016
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
